ZNF691
gene geneOn this page
Also known as Zfp691
Summary
ZNF691 (zinc finger protein 691, HGNC:28028) is a protein-coding gene on chromosome 1p34.2, encoding Zinc finger protein 691 (Q5VV52). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.
Source: NCBI Gene 51058 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 49 total
- MANE Select transcript:
NM_001242739
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28028 |
| Approved symbol | ZNF691 |
| Name | zinc finger protein 691 |
| Location | 1p34.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Zfp691 |
| Ensembl gene | ENSG00000164011 |
| Ensembl biotype | protein_coding |
| Entrez | 51058 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 17 protein_coding
ENST00000372502, ENST00000372503, ENST00000372504, ENST00000372506, ENST00000372507, ENST00000372508, ENST00000397034, ENST00000630961, ENST00000651192, ENST00000886192, ENST00000886193, ENST00000886194, ENST00000886195, ENST00000886196, ENST00000925308, ENST00000948352, ENST00000948353
RefSeq mRNA: 2 — MANE Select: NM_001242739
NM_001242739, NM_015911
CCDS: CCDS476, CCDS55595
Canonical transcript exons
ENST00000651192 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001457978 | 42849291 | 42849413 |
| ENSE00001527102 | 42849565 | 42849742 |
| ENSE00003474468 | 42850950 | 42852477 |
| ENSE00003848131 | 42846613 | 42846657 |
Expression profiles
Bgee: expression breadth ubiquitous, 174 present calls, max score 87.78.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.9482 / max 81.3311, expressed in 1781 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 2480 | 9.9482 | 1781 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.78 | gold quality |
| right lobe of liver | UBERON:0001114 | 86.27 | gold quality |
| apex of heart | UBERON:0002098 | 84.31 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.24 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 83.52 | gold quality |
| right adrenal gland | UBERON:0001233 | 82.64 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 82.44 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 82.15 | gold quality |
| granulocyte | CL:0000094 | 81.98 | gold quality |
| ventricular zone | UBERON:0003053 | 81.92 | gold quality |
| thyroid gland | UBERON:0002046 | 81.61 | gold quality |
| spleen | UBERON:0002106 | 81.59 | gold quality |
| left adrenal gland | UBERON:0001234 | 81.50 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 81.46 | gold quality |
| body of uterus | UBERON:0009853 | 81.18 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 81.04 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 80.95 | gold quality |
| lower esophagus | UBERON:0013473 | 80.92 | gold quality |
| stromal cell of endometrium | CL:0002255 | 80.91 | gold quality |
| adrenal cortex | UBERON:0001235 | 80.83 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 80.80 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 80.74 | gold quality |
| right ovary | UBERON:0002118 | 80.73 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 80.70 | gold quality |
| metanephros cortex | UBERON:0010533 | 80.70 | gold quality |
| endocervix | UBERON:0000458 | 80.69 | gold quality |
| ganglionic eminence | UBERON:0004023 | 80.61 | gold quality |
| left ovary | UBERON:0002119 | 80.35 | gold quality |
| lymph node | UBERON:0000029 | 80.18 | gold quality |
| body of pancreas | UBERON:0001150 | 80.12 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.69 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
53 targeting ZNF691, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-497-5P | 99.92 | 71.83 | 2674 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-15A-5P | 99.90 | 72.80 | 2787 |
| HSA-MIR-15B-5P | 99.90 | 72.78 | 2798 |
| HSA-MIR-16-5P | 99.90 | 72.80 | 2780 |
| HSA-MIR-195-5P | 99.90 | 72.81 | 2805 |
| HSA-MIR-424-5P | 99.89 | 71.90 | 2641 |
| HSA-MIR-6838-5P | 99.89 | 71.94 | 2690 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-204-5P | 99.79 | 71.62 | 2439 |
| HSA-MIR-211-5P | 99.79 | 71.65 | 2440 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-646 | 99.68 | 67.84 | 1645 |
| HSA-MIR-378A-5P | 99.65 | 66.33 | 1311 |
| HSA-MIR-1275 | 99.47 | 67.90 | 2749 |
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp691 | ENSMUSG00000045268 |
Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)
Protein
Protein identifiers
Zinc finger protein 691 — Q5VV52 (reviewed: Q5VV52)
All UniProt accessions (4): A0A0A0MRR1, Q5VV52, Q5VV50, Q5VV51
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5VV52-2 | 1 | yes |
| Q5VV52-3 | 2 |
RefSeq proteins (2): NP_001229668, NP_056995 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF13465
UniProt features (17 total): zinc finger region 7, modified residue 3, compositionally biased region 2, chain 1, cross-link 1, splice variant 1, sequence conflict 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VV52-F1 | 70.14 | 0.37 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (4): 39, 75, 77, 113
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 77 (showing top):
GSE45365_NK_CELL_VS_CD11B_DC_UP, RRAGTTGT_UNKNOWN, chr1p34, ACTWSNACTNY_UNKNOWN, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ASH1L_TARGET_GENES, CEBPZ_TARGET_GENES, HOXC6_TARGET_GENES, KAT2A_TARGET_GENES, PRKDC_TARGET_GENES, TEAD2_TARGET_GENES, ZFHX3_TARGET_GENES
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| transcription by RNA polymerase II | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
486 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF691 | CFAP144 | A6NL82 | 399 |
| ZNF691 | RNF148 | Q8N7C7 | 399 |
| ZNF691 | C1orf50 | Q9BV19 | 395 |
| ZNF691 | FAM149A | A5PLN7 | 355 |
| ZNF691 | PEBP1 | P30086 | 353 |
| ZNF691 | PNLIPRP3 | Q17RR3 | 353 |
| ZNF691 | PNLIP | P16233 | 352 |
| ZNF691 | PNLIPRP1 | P54315 | 352 |
| ZNF691 | UCP2 | P55851 | 350 |
| ZNF691 | SRRT | Q9BXP5 | 343 |
| ZNF691 | PRDX6 | P30041 | 334 |
| ZNF691 | USP39 | Q53GS9 | 329 |
| ZNF691 | CCDC30 | Q5VVM6 | 325 |
| ZNF691 | A0A2R8YGN2 | A0A2R8YGN2 | 322 |
| ZNF691 | LCE5A | Q5TCM9 | 312 |
IntAct
19 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF691 | TRIM41 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF691 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| H3C1 | SMCHD1 | psi-mi:“MI:2364”(proximity) | 0.410 |
| ZNF691 | H1-2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| AKT1 | ZNF691 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ORF4a | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.350 |
| ANOS1 | ZNF724 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF691 | FPGT | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF691 | GDF9 | psi-mi:“MI:0914”(association) | 0.350 |
| LMNA | SMCHD1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| FEV | TAF4 | psi-mi:“MI:2364”(proximity) | 0.270 |
| SP7 | IGF2BP3 | psi-mi:“MI:2364”(proximity) | 0.270 |
| ZNF691 | TRIM41 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF691 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF691 | HAP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (51): ZNF691 (Two-hybrid), ZNF691 (Affinity Capture-MS), ZNF691 (Proximity Label-MS), ZNF691 (Proximity Label-MS), HAP1 (Two-hybrid), ZNF691 (Two-hybrid), ZNF691 (Two-hybrid), ZNF691 (Proximity Label-MS), ZNF691 (Proximity Label-MS), ZNF691 (Proximity Label-MS), ZNF691 (Proximity Label-MS), ZNF691 (Proximity Label-MS), ZNF691 (Proximity Label-MS), ZNF691 (Proximity Label-MS), ZNF691 (Proximity Label-MS)
ESM2 similar proteins: A1YEV9, A1YG26, A1YG48, A1YG60, A2T712, A2T736, A2T7D2, A2T7L7, A6QPT6, B2KFW1, O14771, O14978, O95125, P10073, P17029, P17040, P59923, Q07231, Q15776, Q16587, Q1LZ87, Q3URR7, Q4KLI1, Q4R8H9, Q53GI3, Q5R670, Q5R741, Q5RJ54, Q5VV52, Q63HK3, Q6A085, Q86W11, Q8BGS3, Q8CF60, Q8IWY8, Q8N393, Q8NF99, Q91VW9, Q969J2, Q96GC6
Diamond homologs: Q17QR7, Q3TDE8, Q5VV52, A1L1L7, A1YEV9, A1YG26, A2T712, A2T7L7, B2KFW1, P17022, P18724, P18735, Q07231, Q6A085, Q8CF60, Q96BV0, Q9BXA9, Q9Y5A6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
49 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 46 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
561 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:42849367:C:CG | donor_gain | 1.0000 |
| 1:42849367:C:G | donor_gain | 1.0000 |
| 1:42846654:CGAGG:C | donor_loss | 0.9900 |
| 1:42846655:GAGGT:G | donor_loss | 0.9900 |
| 1:42846658:GTG:G | donor_loss | 0.9900 |
| 1:42846659:T:G | donor_loss | 0.9900 |
| 1:42849366:GC:G | donor_gain | 0.9900 |
| 1:42849371:G:GG | donor_gain | 0.9900 |
| 1:42849381:C:T | donor_gain | 0.9900 |
| 1:42846784:G:T | donor_gain | 0.9800 |
| 1:42846653:GCGAG:G | donor_gain | 0.9700 |
| 1:42850948:AG:A | acceptor_gain | 0.9700 |
| 1:42850949:GG:G | acceptor_gain | 0.9700 |
| 1:42846784:G:GT | donor_gain | 0.9600 |
| 1:42846658:G:GG | donor_gain | 0.9100 |
| 1:42850947:CA:C | acceptor_loss | 0.9100 |
| 1:42850948:A:G | acceptor_loss | 0.9100 |
| 1:42849285:TCACA:T | acceptor_loss | 0.9000 |
| 1:42849286:CACA:C | acceptor_loss | 0.9000 |
| 1:42849288:CA:C | acceptor_loss | 0.9000 |
| 1:42849289:AG:A | acceptor_gain | 0.9000 |
| 1:42849290:G:GC | acceptor_loss | 0.9000 |
| 1:42849290:GG:G | acceptor_gain | 0.9000 |
| 1:42849740:GAG:G | donor_gain | 0.8900 |
| 1:42849315:GTT:G | donor_gain | 0.8800 |
| 1:42849564:GAA:G | acceptor_gain | 0.8800 |
| 1:42849564:GAAAT:G | acceptor_gain | 0.8800 |
| 1:42849660:T:G | acceptor_gain | 0.8800 |
| 1:42850948:A:AG | acceptor_gain | 0.8800 |
| 1:42850949:G:GG | acceptor_gain | 0.8800 |
AlphaMissense
2083 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:42851487:T:C | F208L | 1.000 |
| 1:42851489:C:A | F208L | 1.000 |
| 1:42851489:C:G | F208L | 1.000 |
| 1:42851319:T:C | F152L | 0.999 |
| 1:42851321:C:A | F152L | 0.999 |
| 1:42851321:C:G | F152L | 0.999 |
| 1:42851403:T:C | F180L | 0.999 |
| 1:42851405:T:A | F180L | 0.999 |
| 1:42851405:T:G | F180L | 0.999 |
| 1:42851571:T:C | F236L | 0.999 |
| 1:42851573:C:A | F236L | 0.999 |
| 1:42851573:C:G | F236L | 0.999 |
| 1:42851655:T:C | F264L | 0.999 |
| 1:42851657:C:A | F264L | 0.999 |
| 1:42851657:C:G | F264L | 0.999 |
| 1:42851739:T:C | F292L | 0.999 |
| 1:42851741:C:A | F292L | 0.999 |
| 1:42851741:C:G | F292L | 0.999 |
| 1:42851758:T:C | L298P | 0.999 |
| 1:42851235:T:C | F124L | 0.998 |
| 1:42851237:C:A | F124L | 0.998 |
| 1:42851237:C:G | F124L | 0.998 |
| 1:42851269:G:C | R135P | 0.998 |
| 1:42851422:T:C | L186P | 0.998 |
| 1:42851605:G:C | R247P | 0.998 |
| 1:42851689:G:C | R275P | 0.998 |
| 1:42851746:G:C | R294P | 0.998 |
| 1:42851254:T:C | L130P | 0.997 |
| 1:42851264:C:A | H133Q | 0.997 |
| 1:42851264:C:G | H133Q | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000135457 (1:42846974 G>A,C,T), RS1000736104 (1:42848291 G>A), RS1000892530 (1:42845194 A>G), RS1000941393 (1:42845350 T>C), RS1001189350 (1:42848024 T>C), RS1001238607 (1:42850376 G>T), RS1002335351 (1:42850775 T>C), RS1002670861 (1:42852322 G>T), RS1002955464 (1:42846767 C>T), RS1003077105 (1:42844683 G>A), RS1003140483 (1:42850504 A>G,T), RS1003644866 (1:42850236 C>G,T), RS1004119618 (1:42844654 C>A), RS1004172373 (1:42845100 G>A), RS1004420871 (1:42850018 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | affects expression, increases abundance, decreases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| TAK-243 | increases sumoylation | 1 |
| bisphenol A | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| potassium chromate(VI) | decreases expression, affects cotreatment | 1 |
| ferrous chloride | decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| jinfukang | increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Caffeine | increases phosphorylation | 1 |
| Cisplatin | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Potassium Chloride | decreases expression, decreases response to substance | 1 |
| Dronabinol | decreases expression, decreases response to substance | 1 |
| Thiram | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Vincristine | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
| Particulate Matter | increases abundance, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.